The journey of a disease-modifying osteoarthritis drug: From research to reality

Joint Action

Контент предоставлен David Hunter and FRACP (Rheum). Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией David Hunter and FRACP (Rheum) или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

2M ago 37:57

MP3•Главная эпизода

In this week's episode, we explore the quest for a therapy that not only alleviates symptoms of osteoarthritis but also addresses the underlying disease process. Host Professor David Hunter is joined by Chris Knight and Dr Sandeep Basnet from Formation Bio to discuss the complexities and breakthroughs in developing disease-modifying osteoarthritis drugs (DMOADs).

They dive into the challenges of clinical trials, the high stakes of drug development, and the promising future of AI in revolutionising this field.

Tune in to learn how close we are to seeing these game-changing therapies become a reality and what it could mean for millions living with osteoarthritis.

RESOURCES

Formation Bio: https://www.formation.bio/

CONNECT WITH US

Twitter/X: @ProfDavidHunter @jointactionorg
Instagram: @ProfDavidHunter
Email: hello@jointaction.info

Hosted on Acast. See acast.com/privacy for more information.

131 эпизодов

#Fitness #Medicine #David Hunter #FRACP (Rheum #Osteoarthritis #Arthritis #Rheumatology #Physiotherapy #Exercise #Aging #Medicines For Osteoarthritis #Exercises For Osteoarthritis #Opioids And Osteoarthritis #Supplements For Osteoarthritis